Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease – A Prospective Study Between 2016 and 2017 at a Single Center

21 August 2021 : Clinical Research

Zhongliang Dai^1ACDE, Miao Lin^1BDE, Yali Li^1BE, Wenli Gao^1BDE, Ping Wang^1BDE, Juan Lin^1CE, Zhenzhen Wan^2AE, Yuanxu Jiang^1CE*

DOI: 10.12659/MSM.929835

Med Sci Monit 2021; 27:e929835

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Postoperative clinical course of 30 days.

Variables	Sevoflurane (n=81)	Propofol (n=83)	P
Death, n (%)	4 (5.0)	3 (3.6)	0.781
NYHA, n (%)
I	25 (30.9)	24 (28.9)	0.722
II	50 (61.7)	48 (57.8)	0.819
III	17 (21.0)	18 (21.7)	0.863
IV	9 (11.1)	9 (10.8)	0.926
Acute myocardial infarction, n (%)	0	0	---
Arrhythmias requiring treatment, n (%)	5 (6.2)	6 (7.2)	0.832
Cardiac dysfunction, n (%)	2 (2.5)	2 (2.4)	0.956
Readmission, n (%)	8 (9.9)	7 (8.4)	0.682
NYHA – New York Heart Association.

Back to the Article